Strides Arcolab Ltd said on Tuesday it received US Food and Drug Administration nod for labetalol hydrochloride injection.
Labetalol is a generic equivalent of Prometheus Laboratories Trandate (Labetalol HCL) Injection and is used for the treatment of blood pressure in severe hypertension, it said in a statement.
Labetalol is the third product the Indian drugmaker has launched in collaboration with Sagent Pharmaceuticals.
